RETIDINE

This brand name is authorized in Nigeria.

Active ingredients

The drug RETIDINE contains one active pharmaceutical ingredient (API):

1	Loratadine UNII 7AJO3BO7QN - LORATADINE
	Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.
	Read more about Loratadine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-0810	Tablet	Retidine-10 Tablets_ TAB 10 mg 10 x 10's (in Alu PVC blisters)	Tablet 98 RETIDINE-10 TABLETS RETIDINE LORATADINE LORATADINE 1OMG OVER THE COUNTER TABLETS 10 X 10 ANTIHISTAMINE VIXA PHARMA CO.LTD 13B, SUNNY JIGIDE STREET, OFF CELESTIAL WAY, OGUDU, LAGOS JIANGSU RUINIAN QIANJIN PHARMA. CO. LTD, CHUANBU VILLAGE, DINSHU TOWN, YIXING CITY, JIANGSU, CHINA. A4-0810 SYMPTOMATIC RELIEF OF ALLERGIES; HAYFEVER, URTICARIA 03/29/2021 03/28/2026	29/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R06AX13	Loratadine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-0810